CarePay International is thrilled to announce that we have successfully raised $10 million in our latest funding round, a milestone that reinforces our commitment to transforming healthcare access across Africa. Launched in 2015, our innovative mobile health wallet, M-TIBA, was designed to empower individuals in Kenya to save for future medical expenses using mobile technology and e-money. Over the years, our platform has evolved into a robust digital connector linking healthcare payers, providers, and members, streamlining the financial aspects of the healthcare journey. This funding will enable us to expand upon our mission of enhancing the flow of funds within healthcare systems, ultimately reducing costs and improving access to quality care for millions. As healthcare costs continue to escalate, our team is dedicated to scaling M-TIBA to other countries grappling with similar challenges, driven by a vision to ensure that quality healthcare is within everyone’s reach. Our talented and passionate team across Kenya, Nigeria, and The Netherlands is at the heart of this mission, constantly seeking innovative ways to advance HealthTech solutions that make a real impact. We believe that personal and professional development is crucial to our success, and we prioritize collaborative efforts to drive transformative change in the healthcare landscape. If you’re motivated to create a meaningful impact from day one and share our vision for a healthier future, we invite you to connect with us. Together, we can build a better healthcare system for all.
CarePay International Secures $10 Million Investment: Revolutionizing Healthcare Access Worldwide
Get the full CarePay International company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Anveshan
We are a food-tech startup aiming to provide high quality deeply traceable food products. We leverage technologies based on image processing, spectroscopy, blockchain and IOT to provide the best quality food products made traditionally.
$12.7M Series b
today
Caseway
We are the only enterprise AI form platform that replaces internal R&D and manual workflows by building and maintaining fully integrated automation systems, aligned to your data, your processes, and your long-term success. For document-intensive, compliance-driven organizations in regulated industries like insurance, education, finance, healthcare, and government Compelling reason to buy: Who need AI and automation tailored to their unique forms, workflows, and security environment, without having to shoulder R&D risk or manage AI development internally Product category: Our product is an enterprise document form platform Key benefit: That delivers a fully integrated, continuously improving automation system, built and maintained by experts, without upfront AI build costs Key differentiation: Our product is custom-built for each client’s systems and documents, fully integrated and continuously improved through a long-term partnership model, we maintain, debug, adapt, and align incentives to make it work in the real world.
$1.5M Pre-seed
today
Kubera Health
Kubera’s mission is to power a payment ecosystem where contracts are honored, care is rewarded, and waste is eliminated. We deliver contract and payment intelligence that unifies policies, terms, and claims data into one trusted platform — helping healthcare organizations and their partners build fairer contracts, ensure payments flow as intended, and align incentives across the care ecosystem. As healthcare shifts toward new reimbursement models and risk-sharing arrangements, Kubera is building the payment-intelligence backbone that enables multiple parties to adapt faster, protect margins, and dedicate more resources to patient care.
$6.5M Seed
today
Psilera
Psilera is a biotechnology company founded by scientists dedicated to finding better therapeutics for neurological conditions like dementia, addiction, and mental health disorders. Since 2019, Psilera has been focused on early-stage drug discovery & development with a dynamic team of experts in synthetic chemistry, pharmacology, clinical development, and business development.
$8.8M Seed
today
Abstract
Abstract is a venture capital firm based in San Francisco with $1.5 billion in assets under management. We are sector-agnostic, focused on seed and early stage founders. Our reputation among founders is built on fierce loyalty, unparalleled connections, and a relentless drive to help them win.
$59.0M Series a
today